[{"address1": "3655 Nobel Drive", "address2": "Suite 260", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 926 7655", "website": "https://darebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dar\u00e9 Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Dar\u00e9 Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sabrina Martucci Johnson", "age": 57, "title": "CEO, President, Principal Financial Officer, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 641406, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. MarDee J. Haring-Layton", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 409800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Walters", "age": 69, "title": "Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Friend Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.4, "open": 2.39, "dayLow": 2.39, "dayHigh": 2.39, "regularMarketPreviousClose": 2.4, "regularMarketOpen": 2.39, "regularMarketDayLow": 2.39, "regularMarketDayHigh": 2.39, "payoutRatio": 0.0, "beta": 1.205, "forwardPE": -1.7647059, "volume": 9996, "regularMarketVolume": 9996, "averageVolume": 25026, "averageVolume10days": 47230, "averageDailyVolume10Day": 47230, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 21240936, "fiftyTwoWeekLow": 2.35, "fiftyTwoWeekHigh": 4.6, "priceToSalesTrailing12Months": 819.8285, "fiftyDayAverage": 2.8831, "twoHundredDayAverage": 3.160545, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14395083, "profitMargins": 0.0, "floatShares": 8711877, "sharesOutstanding": 8850390, "sharesShort": 46018, "sharesShortPriorMonth": 60806, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0052, "heldPercentInsiders": 0.01565, "heldPercentInstitutions": 0.09405, "shortRatio": 1.81, "shortPercentOfFloat": 0.0053, "impliedSharesOutstanding": 8850390, "bookValue": -1.081, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -1676550, "trailingEps": -0.17, "forwardEps": -1.36, "lastSplitFactor": "1:12", "lastSplitDate": 1719792000, "enterpriseToRevenue": 555.602, "enterpriseToEbitda": -0.66, "52WeekChange": -0.223301, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 2.4, "targetHighPrice": 14.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.0, "targetMedianPrice": 13.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 10329967, "totalCashPerShare": 1.167, "ebitda": -21820472, "totalDebt": 3572627, "quickRatio": 0.493, "currentRatio": 0.558, "totalRevenue": 25909, "revenuePerShare": 0.003, "returnOnAssets": -0.86977994, "grossProfits": -13215486, "freeCashflow": -5846435, "operatingCashflow": 6736666, "revenueGrowth": 1.734, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -180.16747, "financialCurrency": "USD", "symbol": "DARE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1751572028, "regularMarketTime": 1751562001, "exchange": "NCM", "messageBoardId": "finmb_423979060", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1397136600000, "postMarketChangePercent": -0.416666, "postMarketPrice": 2.39, "postMarketChange": -0.00999999, "regularMarketChange": 0.0, "regularMarketDayRange": "2.39 - 2.39", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 25026, "fiftyTwoWeekLowChange": 0.05000019, "fiftyTwoWeekLowChangePercent": 0.021276677, "fiftyTwoWeekRange": "2.35 - 4.6", "fiftyTwoWeekHighChange": -2.1999998, "fiftyTwoWeekHighChangePercent": -0.47826084, "fiftyTwoWeekChangePercent": -22.3301, "dividendDate": 1500508800, "earningsTimestamp": 1747166460, "earningsTimestampStart": 1754909940, "earningsTimestampEnd": 1755259200, "earningsCallTimestampStart": 1747168200, "earningsCallTimestampEnd": 1747168200, "isEarningsDateEstimate": true, "marketState": "CLOSED", "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.4, "shortName": "Dare Bioscience, Inc.", "longName": "Dar\u00e9 Bioscience, Inc.", "epsTrailingTwelveMonths": -0.17, "epsForward": -1.36, "epsCurrentYear": -1.91333, "priceEpsCurrentYear": -1.2543577, "fiftyDayAverageChange": -0.48309994, "fiftyDayAverageChangePercent": -0.16756266, "twoHundredDayAverageChange": -0.760545, "twoHundredDayAverageChangePercent": -0.24063729, "priceToBook": -2.2201667, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Dar\u00e9 Bioscience", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]